Enzyme Targets

The enzyme family has proven to be a rich source of druggable targets over
the decades, yet it still continues to deliver many exciting new
candidates for drug development in as yet untapped areas such as
epigenetics, cancer and cardiovascular disease.  In the session we will
explore the wide diversity of the enzyme family members that are at the
forefront of current drug discovery and highlight the advantages and
challenges of working in the area.